Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Groot

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2000
Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient miceM Van Eck, M P De Winther, N Herijgers, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonistsJ Witherington, V Bordas, D G Cooper, et al.
Atherosclerosis|September 23, 1997
SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesisT A Berkhout, H M Simon, B Jackson, et al.
European Journal of Biochemistry|March 1, 1992
Cloning and expression of a human ATP-citrate lyase cDNAN A Elshourbagy, J C Near, P J Kmetz, et al.
The Biochemical Journal|August 7, 1998
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076N J Pearce, J W Yates, T A Berkhout, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1991
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery diseaseP H Groot, W A van Stiphout, X H Krauss, et al.
The Journal of Biological Chemistry|January 25, 1990
Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and ageN A Elshourbagy, J C Near, P J Kmetz, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compoundI T Forbes, D G Cooper, E K Dodds, et al.
Arzneimittel-Forschung|June 3, 1998
Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugsB J van Vlijmen, N J Pearce, M Bergö, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 9, 2005
Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob miceAldo Grefhorst, Theo H van Dijk, Anke Hammer, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2000
Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient miceM Van Eck, M P De Winther, N Herijgers, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonistsJ Witherington, V Bordas, D G Cooper, et al.
Atherosclerosis|September 23, 1997
SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesisT A Berkhout, H M Simon, B Jackson, et al.
European Journal of Biochemistry|March 1, 1992
Cloning and expression of a human ATP-citrate lyase cDNAN A Elshourbagy, J C Near, P J Kmetz, et al.
The Biochemical Journal|August 7, 1998
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076N J Pearce, J W Yates, T A Berkhout, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1991
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery diseaseP H Groot, W A van Stiphout, X H Krauss, et al.
The Journal of Biological Chemistry|January 25, 1990
Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and ageN A Elshourbagy, J C Near, P J Kmetz, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compoundI T Forbes, D G Cooper, E K Dodds, et al.
Arzneimittel-Forschung|June 3, 1998
Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugsB J van Vlijmen, N J Pearce, M Bergö, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 9, 2005
Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob miceAldo Grefhorst, Theo H van Dijk, Anke Hammer, et al.
Pageof 8